News

Revolutionizing Risk Management with AI: DXC's New Solution

Revolutionizing Risk Management with AI: DXC's New Solution

Revolutionizing Risk Management with AI

In the evolving landscape of healthcare and employee management, DXC Technology (NYSE: DXC) has introduced an innovative solution known as DXC Assure Risk Management. This cutting-edge platform effortlessly merges artificial intelligence with human expertise to support self-insured organizations. With a focus on improving employee care, managing healthcare costs, and enhancing return-to-work outcomes, this solution seeks to transform how businesses handle their risk management processes.

Understanding Self-Insurance Challenges

Self-insured organizations typically utilize their own funds to handle employee insurance claims, which often leads to unique challenges. These businesses strive to deliver effective care while navigating rigorous regulations, all while grappling with rising healthcare costs. Additionally, they aim to achieve better outcomes for employees returning to work. Given these challenges, a robust solution like DXC Assure Risk Management is essential for streamlining their processes.

Key Features of DXC Assure Risk Management

The DXC Assure Risk Management platform is designed to be both comprehensive and flexible. It effectively addresses the significant challenges faced by self-insured organizations with the following key features:

1. AI-Enabled Processes

The incorporation of intelligent automation throughout the claims workflow significantly mitigates operational risks. With integrated health and safety management tools, the platform allows organizations to enhance their operational efficiency.

2. Expertise at the Core

At the heart of this innovative solution lies a specialized team equipped with deep knowledge in insurance. This team supports the entire claims lifecycle, offering services such as sentiment analysis and proactive claims prevention to ensure a comprehensive approach to managing employee claims.

3. SaaS Technology

This modern, end-to-end, persona-driven system boasts document automation and real-time dashboards. Generative AI capabilities are seamlessly embedded throughout the process, which aids in improving overall outcomes. This technology reflects DXC's commitment to providing valuable solutions for its customers.

A Commitment to Innovation

As Ray August, President of Insurance Software and BPS at DXC Technology, notes, "We are proud to introduce DXC Assure Risk Management, an innovative solution that combines expert people, AI workflows, and technology to help self-insured employers manage the full claims lifecycle from care to cost for their injured employees." This statement underscores DXC's dedication to continuous innovation in the insurance space.

Furthermore, Nathan Golia, a senior analyst for Celent, emphasizes the need for self-insured organizations to adapt the same efficient management processes as traditional insurers. He asserts that leveraging AI can enhance their operations, allowing for smoother processes and better employee support.

Experience & Trust

DXC Technology brings over 40 years of industry experience, establishing itself as a trusted partner, particularly for 21 of the top 25 insurers. As a leading provider of core insurance systems, DXC focuses on reducing complexity and costs, handling more than 1 billion policies processed on its software.

Learn More About DXC Assure Risk Management

For those interested in exploring the capabilities of DXC Assure Risk Management, further information is available on the [DXC Technology website](https://dxc.com/us/en/offerings/insurance-software-bps/dxc-insurance-software/dxc-assure-risk-management).

About DXC Technology

DXC Technology (NYSE: DXC) is a global leader in providing essential information technology services. The company partners with innovative organizations worldwide, offering tailored solutions that advance industries and streamline operations. With a focus on modernizing systems, incorporating AI-powered intelligence, and prioritizing security, DXC helps clients navigate the complexities of today’s technology landscape.

Frequently Asked Questions

What is DXC Assure Risk Management?

DXC Assure Risk Management is a solution that integrates AI with human expertise to support self-insured organizations in managing their claims effectively.

How does self-insurance work?

Self-insured organizations use their own funds to cover employee insurance claims rather than purchasing traditional insurance policies, which presents unique challenges.

What are the benefits of using AI in claims management?

AI streamlines workflow processes, reduces operational risks, and ensures that organizations can respond more efficiently to claims, ultimately benefiting both the employer and employees.

Who can benefit from DXC Assure Risk Management?

Self-insured organizations looking to enhance their claims management processes and improve employee care can benefit greatly from this solution.

How long has DXC Technology been in the industry?

DXC Technology brings over 40 years of experience in providing IT services, becoming a trusted partner for many leading insurers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 17

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 9

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 8

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 11

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 19

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 19

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading

Top 5 Most Recently Viewed Articles

America's Car-Mart Secures $300 Million Loan for Growth

Updated Category News Views 255

America's Car-Mart Secures Funding for Future Growth America's Car-Mart, Inc. (NASDAQ: CRMT), a leading automotive retailer, has taken a strategic step by closing a significant five-year, $300 million term loan. This loan, managed by the seasoned professionals at Silver Point Capital, L.P., aims to enhance the company’s capital structure and support its long-term growth...

Continue Reading
IASO Bio's Breakthrough Drug Application Acceptance in Singapore

Updated Category News Views 251

IASO Bio’s Major Step Forward with New Drug Application IASO Biotherapeutics, a pioneering biopharmaceutical company dedicated to the advancement of innovative cell therapies and biologics, has reached a significant milestone. The Singapore Health Sciences Authority (HSA) has officially accepted the New Drug Application (NDA) for Equecabtagene Autoleucel, known as...

Continue Reading
Creating Community Leaders: National Heritage Academies and United Way

Updated Category News Views 150

Empowering Students to Make a Difference The student-led organization is providing career opportunities while connecting with the community. National Heritage Academies® (NHA) is thrilled to celebrate its collaboration with United Way through the Student United Way program. This initiative equips high school students with essential tools and opportunities to enact...

Continue Reading
Future Growth of Augmented and Virtual Reality Technologies

Updated Category News Views 259

Exploring the Growth of Augmented Reality and Virtual Reality Market The global market for Augmented Reality (AR) and Virtual Reality (VR) is on the rise, with expectations of substantial growth over the next few years. Analysts estimate that this sector will expand by approximately USD 442.99 billion between 2024 and 2028. The compound annual growth rate (CAGR) for this...

Continue Reading
ImmVira Launches Innovative Exosome, Transforming Cosmetics

Updated Category News Views 407

ImmVira Leads the Way with Groundbreaking Exosome Technology In a remarkable advancement for the cosmetic industry, ImmVira Group has announced its innovative product, MVR-EX103, an engineered exosome specifically developed for treating superficial skin depressions. This development marks a pivotal moment, as it has successfully acquired the International Nomenclature...

Continue Reading